What's Going On With Jaguar Health Stock?
Portfolio Pulse from Erica Kollmann
Jaguar Health, Inc. (NASDAQ:JAGX) shares surged, reaching a high of 66 cents during premarket trading on Thursday. The company is exhibiting at the Veterinary Cancer Society Annual Conference to promote its FDA-conditionally approved drug, Canalevia-CA1. The stock is moving on extremely heavy trading volume, with over 90 million shares traded, far exceeding the 100-day average volume of just over 833 thousand shares. The shares are up 93% at 47 cents at the time of publication.
October 12, 2023 | 2:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jaguar Health's stock surged due to the promotion of its FDA-approved drug and heavy trading volume. The stock is up 93% at 47 cents.
The surge in Jaguar Health's stock can be attributed to the promotion of its FDA-approved drug at a conference, which likely increased investor confidence in the company's prospects. Additionally, the heavy trading volume indicates strong investor interest, which can drive up the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100